[Effect of a combination of dihydroergocristine methanesulfonate, clopamide and reserpine on blood pressure and renal hemodynamics in renal and essential hypertension].
D000328:Adult; D000368:Aged; D000577:Amides / Q000494:pharmacology*; D000959:Antihypertensive Agents / Q000627:therapeutic use*; D001158:Arteries; D001161:Arteriosclerosis / Q000150:complications; D001794:Blood Pressure / Q000187:drug effects; D003005:Clopamide / Q000494:pharmacology / Q000627:therapeutic use; D003864:Depression, Chemical; D004232:Diuretics / Q000494:pharmacology*; D004876:Ergot Alkaloids / Q000494:pharmacology* / Q000627:therapeutic use; D006439:Hemodynamics / Q000187:drug effects*; D006801:Humans; D006977:Hypertension, Renal / Q000188:drug therapy*; D007674:Kidney Diseases / Q000188:drug therapy; D007677:Kidney Function Tests; D008875:Middle Aged; D010880:Piperidines / Q000494:pharmacology*; D012110:Reserpine / Q000494:pharmacology* / Q000627:therapeutic use
D000577:Amides; D000959:Antihypertensive Agents; D004232:Diuretics; D004876:Ergot Alkaloids; D010880:Piperidines; D003005:Clopamide; D012110:Reserpine
Zur Wirkung einer Kombination aus Dihydroergocristin-methansulfonat, Clopamid und Reserpin auf Blutdruck und Nierenhämodynamik bei renaler und essentieller Hypertonie.